/
MARKET IS OPEN
Loading latest tickers...

Market Indices

S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%

Sector Heatmap

Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%

AKTS — Aktis Oncology, Inc. Common stock

Nasdaq

Aktis Oncology, Inc. Common stock

Back to Screener
$18.52
-0.95(-4.88%)
O
19.41
H
20.08
L
18.31
V
292.22K
⏱️ End-of-day dataAs of Oct 1, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Aktis Oncology, Inc. Common stock Statistics

Total Valuation

Market Cap$1.08B
Enterprise Value$1.05B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding55.62M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ration/a
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earnings-57.50
EV / Salesn/a
EV / EBITDA-47.78
EV / EBIT-46.40
EV / FCF-40.38

Financial Position

Current Ratio1.95
Quick Ration/a
Debt / Equity-0.78
Debt / EBITDA-0.46
Debt / FCF-0.39
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)140.82%
Return on Assets (ROA)-31.77%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$-231,962
Employee Count79
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+18519900.56%
50-Day Moving Average$23.49
200-Day Moving Average$19.69
Relative Strength Index (RSI)19.04
Average Volume (20 Days)492,585

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profitn/a
Operating Income-$22.71M
Pretax Income-$18.32M
Net Income-$18.32M
EBITDA-$22.05M
EBIT-$22.71M
Loss Per Share$-0.38

Balance Sheet

Cash & Cash Equivalents$37.16M
Total Debt$10.15M
Net Cash$27.02M
Net Cash Per Share$0.49
Equity (Book Value)-$13.01M
Book Value Per Share$-0.23
Working Capital$26.48M

Cash Flow

Operating Cash Flow-$21.06M
Capital Expenditures-$1.85M
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$26.10M
FCF Per Share$-0.47

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yieldn/a
FCF Yield-2.41%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a